Advertisement

Markov Model for Selection of Aortic Valve Replacement Versus Transcatheter Aortic Valve Implantation (Without Replacement) in High-Risk Patients

Published:February 16, 2012DOI:https://doi.org/10.1016/j.amjcard.2011.12.030
      Comparisons between transcatheter aortic valve implantation without replacement (TAVI) and tissue aortic valve replacement (AVR) in clinical trials might not reflect the outcomes in standard clinical practice. This could have important implications for the relative cost-effectiveness of these alternatives for management of severe aortic stenosis in high-risk patients for whom surgery is an option. The mean and variance of risks, transition probabilities, utilities, and cost of TAVI, AVR, and medical management derived from observational studies were entered into a Markov model that examined the progression of patients between relevant health states. The outcomes and cost were derived from 10,000 simulations. Sensitivity analyses were based on variations in the likelihood of mortality, stroke, and other commonly observed outcomes. Both TAVI and AVR were cost-effective compared to medical management. In the reference case (age 80 years, the perioperative TAVI and AVR mortality was 6.9% vs 9.8%, and annual mortality was 21% vs 24%), the utility of TAVI was greater than that of AVR (1.78 vs 1.72 quality-adjusted life years) and the lifetime cost of TAVI exceeded that of AVR ($59,503 vs $56,339). The incremental cost-effectiveness ratio was $52,773/quality-adjusted life years. Threshold analyses showed that variation in the probabilities of perioperative and annual mortality after AVR and after TAVI and annual stroke after TAVI were important determinants of the favored strategy. Sensitivity analyses defined the thresholds at which TAVI or AVR was the preferred strategy with regard to health outcomes and cost. In conclusion, TAVI satisfies current metrics of cost-effectiveness relative to AVR and might provide net health benefits at acceptable cost for selected high-risk patients among whom AVR is the current procedure of choice.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schwarz F.
        • Baumann P.
        • Manthey J.
        • Hoffmann M.
        • Schuler G.
        • Mehmel H.C.
        • Schmitz W.
        • Kübler W.
        The effect of aortic valve replacement on survival.
        Circulation. 1982; 66: 1105-1110
        • Leon M.B.
        • Smith C.R.
        • Mack M.
        • Miller D.C.
        • Moses J.W.
        • Svensson L.G.
        • Tuzcu E.M.
        • Webb J.G.
        • Fontana G.P.
        • Makkar R.R.
        • Brown D.L.
        • Block P.C.
        • Guyton R.A.
        • Pichard A.D.
        • Bavaria J.E.
        • Herrmann H.C.
        • Douglas P.S.
        • Petersen J.L.
        • Akin J.J.
        • Anderson W.N.
        • Wang D.
        • Pocock S.
        • PARTNER Trial Investigators
        Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
        N Engl J Med. 2010; 363: 1597-1607
        • Smith C.R.
        • Leon M.B.
        • Mack M.J.
        • Miller D.C.
        • Moses J.W.
        • Svensson L.G.
        • Tuzcu E.M.
        • Webb J.G.
        • Fontana G.P.
        • Makkar R.R.
        • Williams M.
        • Dewey T.
        • Kapadia S.
        • Babaliaros V.
        • Thourani V.H.
        • Corso P.
        • Pichard A.D.
        • Bavaria J.E.
        • Herrmann H.C.
        • Akin J.J.
        • Anderson W.N.
        • Wang D.
        • Pocock S.J.
        • PARTNER Trial Investigators
        Transcatheter versus surgical aortic-valve replacement in high-risk patients.
        N Engl J Med. 2011; 364: 2187-2198
      1. Reynolds MR. Cost effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in patients with severe aortic stenosis; results from the PARTNER trial (cohort A). Presented at the Transcatheter Cardiovascular Therapeutics Meeting, San Francisco, California, November 7, 2011.

        • Weisberg H.I.
        • Hayden V.C.
        • Pontes V.P.
        Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?.
        Clin Trials. 2009; 6: 109-118
        • Kalavrouziotis D.
        • Li D.
        • Buth K.J.
        • Légaré J.F.
        The European system for cardiac operative risk evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study.
        J Cardiothorac Surg. 2009; 4: 32
        • Leontyev S.
        • Walther T.
        • Borger M.A.
        • Lehmann S.
        • Funkat A.K.
        • Rastan A.
        • Kempfert J.
        • Falk V.
        • Mohr F.W.
        Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE.
        Ann Thorac Surg. 2009; 87: 1440-1445
        • Grossi E.A.
        • Schwartz C.F.
        • Yu P.J.
        • Jorde U.P.
        • Crooke G.A.
        • Grau J.B.
        • Ribakove G.H.
        • Baumann F.G.
        • Ursumanno P.
        • Culliford A.T.
        • Colvin S.B.
        • Galloway A.C.
        High-risk aortic valve replacement: are the outcomes as bad as predicted?.
        Ann Thorac Surg. 2008; 85: 102-107
        • Thourani V.H.
        • Ailawadi G.
        • Szeto W.Y.
        • Dewey T.M.
        • Guyton R.A.
        • Mack M.J.
        • Kron I.L.
        • Kilgo P.
        • Bavaria J.E.
        Outcomes of surgical aortic valve replacement in high-risk patients: a multi-institutional study.
        Ann Thorac Surg. 2011; 91: 49-56
        • Lefèvre T.
        • Kappetein A.P.
        • Wolner E.
        • Nataf P.
        • Thomas M.
        • Schächinger V.
        • De Bruyne B.
        • Eltchaninoff H.
        • Thielmann M.
        • Himbert D.
        • Romano M.
        • Serruys P.
        • Wimmer-Greinecker G.
        • PARTNER EU Investigator Group
        One year follow-up of the multi-centre European PARTNER transcatheter heart valve study.
        Eur Heart J. 2011; 32: 148-157
        • Thomas M.
        • Schymik G.
        • Walther T.
        • Himbert D.
        • Lefèvre T.
        • Treede H.
        • Eggebrecht H.
        • Rubino P.
        • Colombo A.
        • Lange R.
        • Schwarz R.R.
        • Wendler O.
        One-year outcomes of cohort 1 in the Edwards SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.
        Circulation. 2011; 124: 425-433
        • Rodés-Cabau J.
        • Webb J.G.
        • Cheung A.
        • Ye J.
        • Dumont E.
        • Feindel C.M.
        • Osten M.
        • Natarajan M.K.
        • Velianou J.L.
        • Martucci G.
        • DeVarennes B.
        • Chisholm R.
        • Peterson M.D.
        • Lichtenstein S.V.
        • Nietlispach F.
        • Doyle D.
        • DeLarochellière R.
        • Teoh K.
        • Chu V.
        • Dancea A.
        • Lachapelle K.
        • Cheema A.
        • Latter D.
        • Horlick E.
        Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience.
        J Am Coll Cardiol. 2010; 55: 1080-1090
        • Godino C.
        • Maisano F.
        • Montorfano M.
        • Latib A.
        • Chieffo A.
        • Michev I.
        • Al-Lamee R.
        • Bande M.
        • Mussardo M.
        • Arioli F.
        • Ielasi A.
        • Cioni M.
        • Taramasso M.
        • Arendar I.
        • Grimaldi A.
        • Spagnolo P.
        • Zangrillo A.
        • La Canna G.
        • Alfieri O.
        • Colombo A.
        Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
        JACC Cardiovasc Intv. 2010; 3: 1110-1121
        • Wenaweser P.
        • Pilgrim T.
        • Kadner A.
        • Huber C.
        • Stortecky S.
        • Buellesfeld L.
        • Khattab A.A.
        • Meuli F.
        • Roth N.
        • Eberle B.
        • Erdös G.
        • Brinks H.
        • Kalesan B.
        • Meier B.
        • Jüni P.
        • Carrel T.
        • Windecker S.
        Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality.
        J Am Coll Cardiol. 2011; 58: 2151-2162
        • Arias E.
        • Rostron B.L.
        • Tejada-Vera B.
        United States life tables.
        Natl Vital Stat Rep. 2005; 2010: 1-132
        • Khan S.S.
        • Trento A.
        • DeRobertis M.
        • Kass R.M.
        • Sandhu M.
        • Czer L.S.
        • Blanche C.
        • Raissi S.
        • Fontana G.P.
        • Cheng W.
        • Chaux A.
        • Matloff J.M.
        Twenty-year comparison of tissue and mechanical valve replacement.
        J Thorac Cardiovasc Surg. 2001; 122: 257-269
        • Puvimanasinghe J.P.
        • Steyerberg E.W.
        • Takkenberg J.J.
        • Eijkemans M.J.
        • van Herwerden L.A.
        • Bogers A.J.
        • Habbema J.D.
        Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation.
        Circulation. 2001; 103: 1535-1541
        • Grunkemeier G.L.
        • Li H.H.
        • Naftel D.C.
        • Starr A.
        • Rahimtoola S.H.
        Long-term performance of heart valve prostheses.
        Curr Probl Cardiol. 2000; 25: 73-154
        • Sullivan P.W.
        • Ghushchyan V.
        Preference-based EQ-5D index scores for chronic conditions in the United States.
        Med Decis Mak. 2006; 26: 410-420
        • Spertus J.
        • Peterson E.
        • Conard M.W.
        • Heidenreich P.A.
        • Krumholz H.M.
        • Jones P.
        • McCullough P.A.
        • Pina I.
        • Tooley J.
        • Weintraub W.S.
        • Rumsfeld J.S.
        • Cardiovascular Outcomes Research Consortium
        Monitoring clinical changes in patients with heart failure: a comparison of methods.
        Am Heart J. 2005; 150: 707-715
        • Tengs T.O.
        • Yu M.
        • Luistro E.
        Health-related quality of life after stroke a comprehensive review.
        Stroke. 2001; 32: 964-972
        • Cohen D.J.
        • Breall J.A.
        • Ho K.K.
        • Kuntz R.E.
        • Goldman L.
        • Baim D.S.
        • Weinstein M.C.
        Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease: use of a decision-analytic model.
        Circulation. 1994; 89: 1859-1874
      2. Healthcare Cost and Utilization Project database.
        (Accessed November 15, 2011)
        • ICD-9-CM Coordination and Maintenance Committee
        Meeting—cardiac valve replacement: transcatheter aortic, transapical aortic, and transcatheter pulmonary.
        (Accessed November 15, 2011)
        • Liao L.
        • Anstrom K.J.
        • Gottdiener J.S.
        • Pappas P.A.
        • Whellan D.J.
        • Kitzman D.W.
        • Aurigemma G.P.
        • Mark D.B.
        • Schulman K.A.
        • Jollis J.G.
        Long-term costs and resource use in elderly participants with congestive heart failure in the cardiovascular health study.
        Am Heart J. 2007; 153: 245-252
        • Lee W.C.
        • Christensen M.C.
        • Joshi A.V.
        • Pashos C.L.
        Long-term cost of stroke subtypes among Medicare beneficiaries.
        Cerebrovasc Dis. 2007; 23: 57-65
        • Resnic F.S.
        • Arora N.
        • Matheny M.
        • Reynolds M.R.
        A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention.
        Am J Cardiol. 2007; 99: 766-770
        • Wu Y.
        • Jin R.
        • Gao G.
        • Grunkemeier G.L.
        • Starr A.
        Cost-effectiveness of aortic valve replacement in the elderly: an introductory study.
        J Thorac Cardiovasc Surg. 2007; 133: 608-613
        • Reynolds M.R.
        • Magnuson E.A.
        • Lei Y.
        • Leon M.B.
        • Smith C.R.
        • Svensson L.G.
        • Webb J.G.
        • Babaliaros V.C.
        • Bowers B.S.
        • Fearon W.F.
        • Herrmann H.C.
        • Kapadia S.
        • Kodali S.K.
        • Makkar R.R.
        • Pichard A.D.
        • Cohen D.J.
        • Placement of Aortic Transcatheter Valves (PARTNER) Investigators
        Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis.
        Circulation. 2011; 124: 1964-1972
        • Vánky F.B.
        • Håkanson E.
        • Svedjeholm R.
        Long-term consequences of postoperative heart failure after surgery for aortic stenosis compared with coronary surgery.
        Ann Thorac Surg. 2007; 83: 2036-2043